Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Paratek Pharmaceuticals

Paratek Pharmaceuticals
1996 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
PRTK STOCK SYMBOL
1 INVESTMENTS
$4.21 SHARE PRICE (As of Tuesday Closing)
Description

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. Omadacycline is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. Sarecycline is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 75 Park Plaza
  • 4th Floor
  • Boston, MA 02116
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Paratek Pharmaceuticals’s full profile, request a free trial.

Paratek Pharmaceuticals Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$2.87 - $12.20 $137M $4.43 -$3.84 348K 32.4M

Paratek Pharmaceuticals Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 103,501 105,316 385,783 247,328
Revenue 20,709 17,117 12,616 29
EBITDA (113,162) (104,129) (83,346) (107,179)
Net Income (123,685) (112,356) (89,069) (111,636)
Total Assets 276,577 300,192 163,698 135,732
Total Debt 262,683 228,959 59,186 38,974
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Paratek Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Paratek Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Paratek Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Paratek Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Paratek Pharmaceuticals Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Catalyst Pharmaceutical Partners Formerly VC-backed Coral Gables, FL 00 000.00 00000000 000.00
0000000 Formerly VC-backed Boston, MA 0000 000000000
00000000 000000000 Failed Transaction (M&A) West Conshohocken, PA 00 000.00 000000&0
000000000(00000000 Formerly VC-backed New York, NY 000 00000 00000000000 00000
000 00000 Corporation Indianapolis, IN 00000 0000
To view this company’s complete list of competitors, request access »

Paratek Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 30-Oct-2014 000000000000000000 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Paratek Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Paratek Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Paratek Pharmaceuticals Executive Team (24)

Name Title Board
Seat
Contact
Info
Evan Loh MD Chief Executive Officer & Board Member
Adam Woodrow Executive & President
Sarah Higgins Chief Financial Officer & Chief Accounting Officer
Douglas Pagán Chief Financial Officer & Director
Stuart Levy MD Co-Founder

11 Former Executives

You’re viewing 5 of 24 executives. Get the full list »

Paratek Pharmaceuticals Board Members (11)

Name Representing Role Since Contact
Info
Evan Loh MD Paratek Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Jeffrey Stein Ph.D Self Board Member 000 0000
Kristine Peterson Paratek Pharmaceuticals Board Member 000 0000
Michael Bigham Paratek Pharmaceuticals Chairman & Board Member 000 0000
Robert Radie Self Board Member 000 0000

3 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »